Related Experiment Video
Updated: Jul 15, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Topical tacrolimus is effective against eczema in Wiskott-Aldrich syndrome (WAS)
Klaus Bienemann1, Sonja Gudowius, Tim Niehues
1Department of Pediatric Oncology, Haematology and immunology, Children's Hospital, UKD, Heinrich Heine University, Moorenstr. 5, 40225 Düsseldorf, Germany.
Unlabelled:
The Wiskott-Aldrich syndrome is a rare X-linked immunodeficiency characterized by microplatelet thrombocytopenia and eczema. Eczema may be severe and facilitate entry of microorganism into the host.
Conclusion:
We report for the first time that eczema in infants with WAS can be effectively treated with topical ttacrolimus.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Acne Infection
